This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: The University of Sydney. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2024
Title: Lenka Munoz: Innovator in Anti-Cancer Compounds
Introduction
Lenka Munoz is a prominent inventor based in New South Wales, Australia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer compounds. With a total of 3 patents to her name, her work is paving the way for new treatments in the fight against cancer.
Latest Patents
Among her latest patents, Lenka has focused on anti-cancer compounds that relate to new pharmaceutical agents. These agents are designed for the treatment of proliferative diseases, specifically targeting brain cancer. The inventions include compounds of formula (I) or pharmaceutically acceptable salts or prodrugs thereof, showcasing her innovative approach to tackling this critical health issue.
Career Highlights
Lenka Munoz is affiliated with the University of Sydney Commercial Development & Industry Partnerships. Her role at this esteemed institution allows her to engage in cutting-edge research and development, contributing to advancements in medical science.
Collaborations
Lenka has collaborated with notable colleagues such as Michael Kassiou and William Jorgensen. These partnerships enhance her research efforts and expand the impact of her inventions in the scientific community.
Conclusion
Lenka Munoz is a trailblazer in the field of anti-cancer research, with her innovative compounds offering hope for new treatment options. Her dedication to advancing pharmaceutical science is evident in her work and collaborations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile